Tema Oncology ETF (NASDAQ:CANC – Get Free Report) saw a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 1,300 shares, a drop of 92.0% from the January 31st total of 16,300 shares. Based on an average daily volume of 19,000 shares, the days-to-cover ratio is presently 0.1 days.
Tema Oncology ETF Price Performance
Shares of NASDAQ CANC opened at $25.64 on Friday. The firm has a 50-day moving average of $25.10 and a 200 day moving average of $27.00. Tema Oncology ETF has a 1 year low of $23.97 and a 1 year high of $30.11. The stock has a market cap of $65.38 million, a P/E ratio of 26.86 and a beta of 1.11.
Tema Oncology ETF Dividend Announcement
The business also recently disclosed a dividend, which was paid on Thursday, December 12th. Shareholders of record on Wednesday, December 11th were paid a dividend of $0.7283 per share. The ex-dividend date was Wednesday, December 11th.
Institutional Inflows and Outflows
Tema Oncology ETF Company Profile
The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.
See Also
- Five stocks we like better than Tema Oncology ETF
- Are Penny Stocks a Good Fit for Your Portfolio?
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Election Stocks: How Elections Affect the Stock Market
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- What Are Dividend Champions? How to Invest in the Champions
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Tema Oncology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Oncology ETF and related companies with MarketBeat.com's FREE daily email newsletter.